Health
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference BOSTON, Jan. 11, 2021 /PRNewswire/ -- Valo Health LLC (Valo), the technology company working to transform the drug discovery and development process and accelerate the creation of life-changin...
2021-01-12 12:26
2062
Laneige Beauty & Life Lab hosted the first global symposium with retinol experts
SEOUL, South Korea, Jan. 12, 2021 /PRNewswire/ -- LANEIGE Beauty & Life Lab of Laneige, a premium functional skincare brand, hosted the first global academic symposium onJanuary 11th. This online symposium was under the theme 'Retinol, the Almighty Anti-Ager: 27 Years of Innovative Research'. <...
2021-01-12 09:00
3118
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41
SHANGHAI, Jan. 11, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the positive phase I clinical results of ASC41 oral ...
2021-01-12 08:30
2926
DarwinHealth Scientists Publish Foundational Research Identifying Regulatory Mechanisms Controlling Cancer Cell States and Drug Response
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the January 11, 2021 online publication in Cell of a landmark paper, "A Modular Master Regulator Landscape Controls Cancer Transcriptional Identity,"[1,2] in whic...
2021-01-12 08:21
2341
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio
MedSkin Solutions Dr. Suwelack AG announces receiving FDA 510(k) clearance for its flagship Med Care product portfolio MatriDerm®. HAMBURG, Germany, Jan. 12, 2021 /PRNewswire/ -- MatriDerm® is a single-use three-dimensional acellular dermal matrix composed of bovine collagen fibers and bovine el...
2021-01-12 04:38
1633
ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance
LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received
FDA clearance for its novel neuroendoscope, the Axonpen System, for
illumination and visualization of intracranial tissue and fluids, and the
controlled aspiration of tissue and/or fluid during surgery.
2021-01-12 01:00
1386
Regent Pacific Announces Key Research Findings On FORTACIN™
HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several key findings on the w...
2021-01-11 23:36
10098
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC). Yuyu Pharma (Yuyu) established its CP team in 2016 with the help of the law firm Kim & Chang. The CP tea...
2021-01-11 22:00
4840
ICON.AI launches World's First Smart Healthcare Device to protect your health at CES 2021
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- ICON.AI unveiled the World 1 st Smart Healthcare Device during CES 2021. &amp;nbsp; World 1st Smart Healthcare Device with Alexa Built-in With just One Touch of the Detachable Health Tracker, the Smart Healthcare Device takes comprehen...
2021-01-11 21:21
2163
PharmAbcine announces a research collaboration with LegoChem Biosciences
DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...
2021-01-11 21:00
1656
Happiness Biotech's E-Commerce Business - Happy Buy, Achieved Over 70% Growth in December
NANPING, China, Jan. 11, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, has achiev...
2021-01-11 21:00
7205
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services
Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire/ -- Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in c...
2021-01-11 19:05
2234
Amazfit Introduces the Ultra-fashionable Amazfit GTR 2e and GTS 2e Smartwatches with Cutting-edge Health and Fitness Features
LAS VEGAS, Jan. 11, 2021 /PRNewswire/ -- Amazfit, a global brand in the wearables market, unveiled the Amazfit GTR 2e and GTS 2e smartwatches at this year's all-digital CES. Featuring the latest fitness tracking features along with an ultra-thin and fashionable design, the two latest additions to...
2021-01-11 18:30
3778
Airnov Made Its Debut at CPhI China
SHANGHAI, Jan. 11 2021 /PRNewswire/ -- Airnov Healthcare Packaging made its debut successfully at the CPhI China 2020 at Shanghai New International Expo Center on December 16-18. The global leader in healthcare packaging attended the event with its latest innovations including HAT® IN desiccant v...
2021-01-11 16:26
2695
Polygiene acquisition expands sustainable offering
STOCKHOLM, Jan. 11, 2021 /PRNewswire/ -- Sweden-based company Polygiene buys British Addmaster Holdings Limited, making it a comprehensive supplier of antimicrobial solutions for both soft and hard surfaces. On one of the last days of the year, an extraordinary general meeting voted in favor of ...
2021-01-11 16:21
7119
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.
SHENZHEN, China, Jan. 11, 2021 /PRNewswire/ -- On January 8, 2021, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) submitted its pivotal phase III clinical trial application (IND) of national class I innovative drug Chiauranib to NMPA, for the treatment...
2021-01-11 11:33
3083
HRH Prince Mohammed bin Salman announces THE LINE at NEOM
A revolution in urban living - Free of cars and streets, residents will have nature and all daily needs within a five-minute walk - To create 380,000 jobs of the future and contribute SAR 180bn ($48bn) to GDP by 2030 - 170km linear development of hyper-connected AI-enabled communities powered ...
2021-01-11 08:32
5051
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference
SHANGHAI and SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology an...
2021-01-11 07:26
2136
Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Standigm Inc.("Standigm"), an AI-based drug discovery company and SK Chemicals Co., Ltd.("SK Chemicals"), a life science and green chemicals company, announced that they had successfully found a new arthritis indication for an FDA-approved drug an...
2021-01-11 07:00
1985
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...
2021-01-10 16:55
3841
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 292 media titles]
2026-01-05 12:14
Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 290 media titles]
2026-01-08 09:05Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45
Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 283 media titles]
2026-01-08 12:01
Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 282 media titles]
2026-01-07 10:00
Most Read
Supermicro Announces Support for Upcoming NVIDIA Vera Rubin NVL72, HGX Rubin NVL8 and Expanded Rack-Scale Manufacturing Capacity for Liquid-Cooled AI Solutions
2026-01-06 07:00
5119
YY Group Expands into Egypt's USD 20 Billion Hospitality Market
2026-01-05 21:30
4920
Samsung unveils hero products from its 2026 product line-up ahead of CES 2026
2026-01-03 07:22
4820